Technology | Ultrasound Women's Health | December 03, 2018

GE Healthcare Introduces Invenia ABUS 2.0

Updated automated breast ultrasound system features improved data acquisition, patient comfort enhancements

GE Healthcare Introduces Invenia ABUS 2.0

December 3, 2018 — GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This device is the only U.S. Food and Drug Administration (FDA)-approved ultrasound supplemental breast screening technology, according to GE, specifically designed for detecting cancer in dense breast tissue. When used in addition to mammography, Invenia ABUS can improve breast cancer detection by 55 percent over mammography[1] alone.[2]

“We are committed to informing patients about breast density, and offering supplemental screening options,” said Sophia Roumanis, M.D., section head of breast imaging and intervention, Beaumont Breast Care Center, Dearborn, Mich. “We are thrilled to add this advanced ultrasound technology to our breast cancer screening program, which allows better visibility of dense breast tissue during breast cancer screenings.”

More than 40 percent of women in the U.S. have dense breast tissue[3], which is one of the strongest common risk factors for developing breast cancer. Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Both cancer and dense tissue appear white on a mammogram, so looking for tumors in women with dense breasts can be like looking for a snowball in a snowstorm. Because of this, tumors are often unseen – or “masked” – on mammography exams.

“Our goal is to find cancers as early as possible to offer the best potential outcome for the patient,” commented Vidya Pai, M.D., section head of breast imaging and intervention, Beaumont Hospital, Royal Oak, Mich. “By offering this supplemental screening to mammography for patients with dense breast tissue, we anticipate improving detection for small cancers that may not be seen on a mammogram alone in these women.”

Launched in 2014, Invenia ABUS has been installed at hundreds of facilities around the world. The new Invenia ABUS 2.0 builds on its predecessor to enhance the exam experience for both operators and patients, including new features that further customize the exam based on the patient’s body:

  • Efficient exams: The cSound Imageformer, a software-based graphics processor, provides a reproducible and operator-independent acquisition method to achieve consistent, high-quality results. cSound imaging allows significantly more data to be collected and used to create every image. Traditional hand-held ultrasound parameters such as focal zones and gain are automatically optimized. No image manipulation is required, so that high image quality is consistent from operator to operator with the touch of a button; and
  • Improving the patient experience: The gentle shape of the Reverse Curve transducer follows the natural contour of the breast, providing patient comfort, thorough contact and helping ensure comprehensive coverage. The 15 cm large field-of-view transducer is easy to position and maintains even compression while scanning. Since no two women are identical, exams can be customized with programmable scan protocols, adjustable scan depths and compression levels. With the touch of a button, the operator can also shorten scan time once breast tissue acquisition is complete.

For more information: www.gehealthcare.com

 

References

[1] Increase in cancer detection associated with an overall decrease in false positives.

[2] Brem RF, Tabár L, et.al. Assessing Improvement in Detection of Breast Cancer with Three-dimensional Automated Breast US in Women with Dense Breast Tissue: The SomoInsight Study. Radiology. 2015 Mar; 274(3): 663-73.

[3] https://ww5.komen.org/Breastcancer/Highbreastdensityonmammogram.html

 

Related Content

FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
USEI Introduces Window-based iPad Medical Imaging Viewing Solution at RSNA 2018
Technology | Flat Panel Displays | December 06, 2018
U.S. Electronics Inc. (USEI) recently announced the release of what it calls the world’s first Windows-compatible...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Siemens Healthineers Debuts Magnetom Altea 1.5T MRI Scanner
Technology | Magnetic Resonance Imaging (MRI) | December 06, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...